


| Key | % Net Assets | 
|---|---|
| 6.9% | |
| 5.5% | |
| 5.0% | |
| 5.0% | |
| 77.6% | 
| Name | % Net Assets | 
|---|---|
| AstraZeneca | 6.9% | 
| Vodafone Group | 5.5% | 
| Resolution | 5.0% | 
| BP | 5.0% | 
| GlaxoSmithKline | 5.0% | 
| Rentokil Initial | 4.1% | 
| Morrison Supermarkets | 3.9% | 
| Lloyds Banking Group | 3.7% | 
| Royal Bank of Scotland Group | 3.5% | 
| Barclays | 3.4% | 
| Key | % Net Assets | 
|---|---|
| 30.00% | |
| 18.00% | |
| 17.40% | |
| 10.10% | |
| 7.80% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 15,490.00p | 
| Currency | GBP | 
| Change | 0.000p | 
| % | n/a | 
| YTD change | 2,180.00p | 
| YTD % | 16.38% | 
| Fund Inception | 31/05/1987 | 
|---|---|
| Fund Manager | Kevin Murphy / Nick Kirrage | 
| TER | 1.66 (25-Feb-2012) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | n/a | 
| Savings | £50 | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.12 | 
You are here: research